Oral cancer drug developer LightOx joins Newcastle Helix eco-system
LightOx, a company developing new oral cancer treatments has announced its move to The
Biotech company developing nanorobots to improve cancer diagnosis joins Newcastle Helix
A Newcastle biotech, specialising in nanorobotic technology to improve the diagnosis of some of
Accelerating Drug Discovery with the Medicines Discovery Catapult
Accelerating Drug Discovery with the Medicines Discovery Catapult Alexander Henzing, Head of Business Development,
Newcastle Helix life science cluster to host virtual careers event
The Biosphere, a specialist lab facility on Newcastle Helix is hosting an online careers
Careers in Life Sciences: Making the move from academia to industry
The Biosphere are delighted to be hosting this online event all about Careers in
North East health and life sciences sector leads the way in global COVID response
The North East Local Enterprise Partnership (LEP) has praised the region’s health and life
LegoChem Biosciences and Iksuda Therapeutics expand License Agreement for development of antibody-drug conjugates
Expanded agreement grants Iksuda access to Legochem Biosciences’ next generation ADC platform for up
Iksuda Therapeutics closes $47 million financing round
Funding to accelerate clinical progression of Iksuda’s pipeline of new generation of antibody drug
5 minutes with Alcyomics
Alcyomics are one of four businesses based in The Biosphere that received a share
Flagship healthcare project secures first stage funding
A £210m national flagship science and healthcare project, to be delivered from the North